Comments

Cognition Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Cognition Therapeutics (CGTX) operate in?

Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

CGTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q4 2024 Earnings were released on Thu Mar 20th, before the market open

The most recent conference call was at 8:00 AM, 4 days ago Click to view past webcast

Cognition Therapeutics (CGTX) Forecast

News Earnings Cognition Therapeutics (CGTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Cognition Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CGTX | Benzinga

Explore Cognition Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CGTX.

Open	$0.45
Close	-
Volume / Avg.	39.21K / 2.15M
Day Range	$0.45 - $0.45
52 Wk Range	0.34 - 2.95
Market Cap	$19.05M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	7.23%
Days to Cover	1

Recent News

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.45
Close	-
Volume / Avg.	39.21K / 2.15M
Day Range	$0.45 - $0.45
52 Wk Range	0.34 - 2.95
Market Cap	$19.05M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	7.23%
Days to Cover	1

About Cognition Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cognition Therapeutics (CGTX) stock?

You can purchase shares of Cognition Therapeutics (NASDAQ:CGTX) through any online brokerage.

View our list of the best stock brokerages

Who are Cognition Therapeutics (CGTX) competitors?

Other companies in Cognition Therapeutics’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and CalciMedica (NASDAQ:CALC).

What is the forecast, or price target, for Cognition Therapeutics (CGTX) stock?

Cognition Therapeutics has a consensus price target of $7.25.

What is the current price for Cognition Therapeutics (CGTX)?

The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $0.4585 last updated March 24, 2025 at 9:41 AM EDT.

Does Cognition Therapeutics (CGTX) pay a dividend?

There are no upcoming dividends for Cognition Therapeutics.

When is Cognition Therapeutics (NASDAQ:CGTX) reporting earnings?

Cognition Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Cognition Therapeutics (CGTX) going to split?

There is no upcoming split for Cognition Therapeutics.

What sector and industry does Cognition Therapeutics (CGTX) operate in?

Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.